Browse studies

Find your next paid study

4,343 recruiting studies matching your filters

Discrete Choice Experiments for HIV Prevention in Atlanta Adolescents- Atlanta

This study applies Social Cognitive Theory to develop behavioral interventions promoting PrEP adherence. It seeks to adapt and test the enhanced HMP app for fe…

HIV Infections

Estimated

~$10 – $750

Actual pay is set by the research site.

Emory UniversityNCT07535346

Phase 2

Safety and Efficacy of the Addition of Nemtabrutinib to Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

This phase II trial studies how well the addition of nemtabrutinib to lisocabtagene maraleucel in treating patients with chronic lymphocytic leukemia/small lym…

Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Fred Hutchinson Cancer CenterNCT07194980

Phase 2

Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study

This phase II trial studies the good and bad effects of the combination of drugs called cabozantinib and nivolumab in treating patients with melanoma or squamo…

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more

Phase 1

A Phase 1 Clinical Trial of Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

This study will assess safety and feasibility of infusing genetically modified autologous T cells transduced to express a chimeric antigen receptor targeting t…

Refractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

C. Babis AndreadisNCT04545762

Phase 4

MINMON-J: An Effectiveness Implementation Pilot Study Evaluating a Low-barrier Hepatitis C Treatment Model in a Jail Setting

The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and comp…

HEPATITIS C (HCV)IncarcerationInjection Drug Use+1 more

Estimated

~$25 – $1,500

Actual pay is set by the research site.

LifespanNCT06953479

Observational

Efficacy and Safety of the CG-100 Intraluminal Bypass Device in Colorectal and Coloanal Anastomoses: Prospective, Open Label, Randomized Trial

A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

Rectal CancerRectal TumorRectal/Anal

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Colospan Ltd.NCT04184973

Phase 3

Implementation of Vancomycin Powder Application in the Emergency Department for Open Fractures

To evaluate the feasibility, safety, and potential efficacy of applying vancomycin powder locally to open fractures in the emergency department prior to defini…

Open Fracture

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Atlantic Health SystemNCT07659886

Phase 2

A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 (Turletricin) Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy of Invasive Mould Infections (TREAT-1)

The purpose of this study is to determine if EL219 is safe and effective compared to liposomal amphotericin B (LAmB) or voricanozole for early treatment of inv…

Invasive Mould Infection

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Elion Therapeutics, Inc.NCT07215273

Observational

A Randomized, Sham-Controlled Clinical Trial Evaluating Individualized Neuromodulation of Cortical Regions Involved in Neurogenic Overactive Bladder in Multiple Sclerosis

Neurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bl…

Neurogenic BladderMultiple SclerosisOveractive Bladder

Estimated

~$10 – $750

Actual pay is set by the research site.

The Methodist Hospital Research InstituteNCT06072703

Phase 1

A Phase 1 Study of IM-1617 in Participants With Advanced Malignancies

This study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors. Participants will have solid tumor cancer that ha…

Colorectal CancerNon-Small Cell Lung CancerBreast Cancer+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Immunome, Inc.NCT07578571

Phase 2

Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: a Single-dose Challenge Study

The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (N…

Autism Spectrum Disorder

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Stanford UniversityNCT04278898

Observational

A Prospective Diagnostic Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint in Primary and Secondary/Tertiary Care

The purpose of the study is to measure the difference in the proportion of participants with prespecified patient management actions between a tested intervent…

Subjective Cognitive Impairment

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07140744